Navigation Links
Published clinical trial demonstrates efficacy of Sea-Band for migraine-related nausea
Date:7/25/2012

graine without aura, if nausea was always present as an accompanying symptomatology of their migraine. The patients were treated randomly for a total of six migraine attacks: three with the application of Sea-Band wristbands, which applies continual pressure to the PC6 acupoint (phase SB), and three without it (phase C).

The intensities of nausea at the onset at 30, 60, 120 and 240 minutes were evaluated on a scale from zero to 10. The values were always significantly lower in phase SB than in phase C. Also the number of patients who reported at least a 50 percent reduction in the nausea score was significantly higher in phase SB than in phase C at 30, 60 and 120 minutes. The average nausea scores dropped in the SB phase from 6.36 0.35 in T0, to 4.60 0.39 in T1, to 3.11 0.40 in T2, to 1.88 0.31 in T3 and to 0.92 0.22 in T4. At each time step taken into consideration after the application of the Sea-Band wristbands, there was a statistically significant improvement over the non-treated phases. Moreover, there were a high percentage of responders to the treatment: i.e. 46.8 percent at 60 minutes; 71.8 percent at 120 minutes; 84.3 percent at 240 minutes with a consistent response over time.


'/>"/>
Contact: Stephanie LaDue
sladue@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New CDC study on racial disparities in infant mortality published in Journal of Womens Health
2. Wound care meta-review draws firm conclusions from Cochrane published studies
3. New Anthropology and Archaeology Resources Published at Sciences Social Network
4. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
5. 32-country study shows that type 2 diabetes drug is clinically effective for long-term use
6. Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
7. Access to clinical trials drives dramatic increases in survival from childhood cancer
8. Interactive personal health records increase clinical preventive services
9. University of Minnesota licenses Clinical Decision Support technology
10. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
11. Clinical trial first to test heart drug regimen for Duchenne muscular dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July 31, ... tool that has shown an increased risk of spreading undetected ... from the market. In a letter that was to ... Johnson asked that its laparoscopic power morcellators be returned to ... Sales of new morcellators had been suspended in April ...
(Date:7/31/2014)... The International Bottled Water Association (IBWA) today launched ... called “ Bottled Water – Always there when you need ... bottled water plays in times of natural disasters and other ... busy period for hurricanes and other forms of severe weather, ... to take a moment to re-assess their risks and update ...
(Date:7/31/2014)... July 31, 2014 The team ... Lake Como, NJ, is proud to announce that ... , Advanced PMR proudly offers many services, including ... also offer medical supplies. Some of their physical ... therapy, and geriatric therapy among a vast list ...
(Date:7/31/2014)... All Star Comedy Night will take place on August 7th ... Avery Moskowitz who has Neuroblastoma, a form of childhood cancer. ... both have multiple ties to Avery and her family. Together, ... hard at securing sponsors. Avery's story is being documented daily ... Atlantic Toyota and NY Auto Giant has ...
(Date:7/31/2014)... Ohio (PRWEB) July 31, 2014 In ... that the pharmaceutical giant, Johnson & Johnson, is withdrawing ... it can spread undetected cancer. This important story ... (7/30), USA Today (7/31), the AP (7/30), the Pittsburgh ... morcellator tool is used during uterine procedures to, “slice ...
Breaking Medicine News(10 mins):Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 2Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 3Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 2Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 3Health News:New Video Showcases Bottled Water’s Important Role in Times of Emergencies 4Health News:NJ Top Docs' Approved, Advanced Physical Medicine and Rehabilitation Now Offering Chiropractic & Podiatric Services 2Health News:Local Long Island Massage Day Spa and Auto Dealer Combine Forces to Raise Funds for 4 Year Old Who Has Cancer 2Health News:Local Long Island Massage Day Spa and Auto Dealer Combine Forces to Raise Funds for 4 Year Old Who Has Cancer 3Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 2Health News:Have You Had a Hysterectomy or Removal of Uterine Fibroids? Morcellator Device Withdrawn From Market Due To Cancer Risk 3
... potentially fatal hepatitis C virus (HCV) have received a major ... virus. A team of medical researchers from the University ... of HCV infection, including a number identified within a few ... new technique called next generation deep sequencing and sophisticated computer ...
... has found the first evidence that lifelong musicians experience ... studies have already shown that trained musicians have highly ... first study to examine hearing abilities in musicians and ... 91 years of age. The study was led ...
... Reporter , MONDAY, Sept. 12 (HealthDay News) -- A new ... perhaps because they don,t need to compete with other males ... children. The findings don,t prove that fatherhood directly affects ... in men may detect that they,ve become fathers in the ...
... , MONDAY, Sept. 12 (HealthDay News) -- ... can help treat heart conditions and save lives, but ... life-threatening and costly complications, a new study suggests. ... Rochester, Minn., found that people who develop an infection ...
... at Emory University School of Medicine have identified a ... FOBISIN, targets 14-3-3 proteins, important for the runaway growth ... to see how FOBISIN fits into the clamp-shaped 14-3-3 ... be permanently bonded to the protein. The finding suggests ...
... , MONDAY, Sept. 12 (HealthDay News) -- It,s ... new study finds that the amount of excess weight someone ... that risk even higher. That,s especially worrisome given the ... more years of their lives obese than prior generations, researchers ...
Cached Medicine News:Health News:Breakthrough opens new avenues for hep C vaccine 2Health News:Science finding is music to the ears 2Health News:Testosterone Levels Seem to Fall With Fatherhood 2Health News:Testosterone Levels Seem to Fall With Fatherhood 3Health News:Heart Devices Like Pacemakers Linked to Infections 2Health News:X-ray protein probe leads to potential anticancer tactic 2Health News:Lifetime 'Dose' of Excess Weight Linked to Diabetes Risk 2
(Date:7/31/2014)... SARASOTA, Fla. , July 31, 2014 ... announced today that it has initiated the development of ... ; and that it has selected Quotient Clinical, ... United Kingdom (UK) to run its early ... a Clinical Trial Application (CTA) by the end of ...
(Date:7/31/2014)... CAMPBELL, Calif. , July 31, 2014 ... development of novel interventional devices to facilitate removal of ... financing. Proceeds from the financing will support EU commercialization ... regulatory filings for the Lazarus ReCover™ and Lazarus Cover™ ... "This financing reflects investor confidence in the value ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... New York results of AFF008, a ... disease. PD01A is the first therapy against the protein alpha-synuclein, ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) ... presented at the press conference on the impact a disease-modifying ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Lazarus Effect Closes $5 Million Financing 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
... 10 Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, ... the company on the pain management market.  The company plans to ... a range of products that address both the acute and chronic ... , , , ...
... Inc. (Nasdaq: YDNT ) today announced that its Board of Directors declared a ... to all shareholders of record on May 22, 2010 . , ... The Company also announced that its Board of Directors elected ... 2003 . He has assumed positions of increasing responsibility in the areas of finance, ...
Cached Medicine Technology:Xanodyne Announces Renewed Focus on Pain Management Market 2Xanodyne Announces Renewed Focus on Pain Management Market 3Xanodyne Announces Renewed Focus on Pain Management Market 4Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Announces Election of New Officer 2
Adjustable Velcro© closures at crown and behind the neck distinguish this immediate post-op face and chin garment for maximum support and compression....
Facial Wrap...
Very compressive support for submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Medicine Products: